BAYN.DE vs. MRNA
Compare and contrast key facts about Bayer Aktiengesellschaft (BAYN.DE) and Moderna, Inc. (MRNA).
Performance
BAYN.DE vs. MRNA - Performance Comparison
Loading graphics...
BAYN.DE vs. MRNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BAYN.DE Bayer Aktiengesellschaft | 8.40% | 92.54% | -42.34% | -27.50% | 6.20% | 1.34% | -30.79% | 25.96% | -4.52% |
MRNA Moderna, Inc. | 72.26% | -37.49% | -55.43% | -46.29% | -24.89% | 161.30% | 390.08% | 30.99% | -18.38% |
Different Trading Currencies
BAYN.DE is traded in EUR, while MRNA is traded in USD. To make them comparable, the MRNA values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, BAYN.DE achieves a 8.40% return, which is significantly lower than MRNA's 72.26% return.
BAYN.DE
- 1D
- 1.87%
- 1M
- -1.21%
- YTD
- 8.40%
- 6M
- 35.36%
- 1Y
- 80.65%
- 3Y*
- -10.45%
- 5Y*
- -3.21%
- 10Y*
- -6.01%
MRNA
- 1D
- -1.62%
- 1M
- -4.33%
- YTD
- 72.26%
- 6M
- 83.84%
- 1Y
- 71.87%
- 3Y*
- -32.66%
- 5Y*
- -17.41%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BAYN.DE vs. MRNA — Risk / Return Rank
BAYN.DE
MRNA
BAYN.DE vs. MRNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bayer Aktiengesellschaft (BAYN.DE) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BAYN.DE | MRNA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.00 | 1.09 | +0.92 |
Sortino ratioReturn per unit of downside risk | 2.62 | 1.82 | +0.79 |
Omega ratioGain probability vs. loss probability | 1.36 | 1.22 | +0.14 |
Calmar ratioReturn relative to maximum drawdown | 3.36 | 1.90 | +1.46 |
Martin ratioReturn relative to average drawdown | 10.66 | 3.81 | +6.85 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BAYN.DE | MRNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.00 | 1.09 | +0.92 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.10 | -0.27 | +0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.19 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.16 | 0.20 | -0.04 |
Correlation
The correlation between BAYN.DE and MRNA is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BAYN.DE vs. MRNA - Dividend Comparison
BAYN.DE's dividend yield for the trailing twelve months is around 0.27%, while MRNA has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAYN.DE Bayer Aktiengesellschaft | 0.27% | 0.30% | 0.57% | 7.14% | 4.14% | 4.26% | 5.81% | 3.85% | 4.55% | 2.63% | 2.52% | 1.94% |
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BAYN.DE vs. MRNA - Drawdown Comparison
The maximum BAYN.DE drawdown since its inception was -82.29%, smaller than the maximum MRNA drawdown of -95.30%. Use the drawdown chart below to compare losses from any high point for BAYN.DE and MRNA.
Loading graphics...
Drawdown Indicators
| BAYN.DE | MRNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.29% | -95.38% | +13.09% |
Max Drawdown (1Y)Largest decline over 1 year | -26.21% | -35.51% | +9.30% |
Max Drawdown (5Y)Largest decline over 5 years | -70.42% | -95.38% | +24.96% |
Max Drawdown (10Y)Largest decline over 10 years | -80.34% | — | — |
Current DrawdownCurrent decline from peak | -62.16% | -89.67% | +27.51% |
Average DrawdownAverage peak-to-trough decline | -29.16% | -55.87% | +26.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.27% | 17.21% | -8.94% |
Volatility
BAYN.DE vs. MRNA - Volatility Comparison
The current volatility for Bayer Aktiengesellschaft (BAYN.DE) is 10.40%, while Moderna, Inc. (MRNA) has a volatility of 21.56%. This indicates that BAYN.DE experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BAYN.DE | MRNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.40% | 21.56% | -11.16% |
Volatility (6M)Calculated over the trailing 6-month period | 30.74% | 50.70% | -19.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.04% | 66.67% | -26.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.30% | 65.82% | -33.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.15% | 71.78% | -40.63% |
Financials
BAYN.DE vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between Bayer Aktiengesellschaft and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities